(A, B) Hematoxylin and eosin (H&E) staining of mouse hepatic tissues and epididymal fat pads. After 21-day treatment with vehicle or celastrol, the livers and epididymal fat pads were recovered from …
Data for Figure 1A–D.
Data for Figure 1E, F.
(A) One-week effects of celastrol on the biomarkers of lipid metabolism in liver tissues. After 7-day treatment, total RNAs were extracted from livers and analyzed by quantitative real-time PCR …
Data for Figure 2A–C.
(A) Immunostaining of GRP78 in livers. After 21-day treatment, mouse livers were recovered and stained with antibodies against GRP78 and CD68, whereas 2-(4-Amidinophenyl)-6-indolecarbamidine …
Data for Figure 3A.
Data for Figure 3B.
Data for Figure 3C, D.
(A) Hierarchical cluster analysis of celastrol-regulated differentially expressed genes (DEGs) in high-fat diet (HFD)-induced obese mice. Expression values are determined by next-generation RNA-seq …
Data for Figure 4A–C.
Differentially expressed genes list for comparison.
(A) Western blot analysis for the effects of celastrol on the ER stress biomarkers in palmitate-challenged RAW264.7 cells. RAW264.7 cells were treated with celastrol for 8 hr and subsequently with …
Original immunoblots.
Data for Figure 5B.
(A) Click chemistry biotinylation and affinity isolation of celastrol-bound proteins. Following 24-hr treatment with celastrol-PEG4-alkyne, the cellular proteins were isolated from RAW264.7 cells …
Original immunoblots and figure with the uncropped blots with the relevant bands labeled.
Data for Figure 6C.
(A) Validation of peptide binding to GRP78. After the immobilization of biotinylated GRP78 to the streptavidin-coated Sensor Chip SA, GRP78-targeting peptide (WDLAWMFRLPVG) was pumped into the …
Data for Figure 7A, B.
Original immunoblots and figure with the uncropped blots with the relevant bands labelled.
Data for the structures, HRMS spectrum, 1H NMR spectrum, and 13C NMR spectrum of celastrol analog.
Synthesis route of celastrol analog and data for the structures, HRMS spectrum, 1H NMR spectrum, and 13C NMR spectrum of intermediates.
Data for the structures, HRMS spectrum, 1H NMR spectrum, and 13C NMR spectrum of celastrol-PEG3-biotin.
Data for the structures, HRMS spectrum, 1H NMR spectrum, and 13C NMR spectrum of analog-PEG3-biotin.
Following the challenge with palmitate, RAW264.7 cells were treated with celastrol or celastrol-PEG4-alkyne, washed, fixed, reacted with fluorescence dye AFDye555-picolyl azide. The cells were …
Original immunofluorescence staining result of RAW264.7 cells treated with celastrol-PEG4-alkyne.
Original immunofluorescence staining result of RAW264.7 cells treated with celastrol.
Data for the structures, HRMS spectrum, 1H NMR spectrum, and 13C NMR spectrum of celastrol-PEG4-alkyne.
(A) Images of experimental mice. Diet-induced obese mice were treated with celastrol or analog at the dose of 5.0 mg kg−1 d−1 for 21 days, whereas control mice were fed with normal diet. …
Data for Figure 9B–F.
The in vitro and in vivo results from the present study suggest that celastrol covalently inhibits the chaperone activity of GRP78 and disconnects the transduction of ER stress signals to downstream …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Antibody | Anti-GRP78 (rabbit polyclonal) | Abcam | Cat. #: ab21685 | WB (1:1000)IF (1:500) |
Antibody | Anti-IRE1α (rabbit monoclonal) | Cell Signaling Technology | Cat. #: 3294 | WB (1:1000) |
Antibody | Anti-XBP1 (rabbit polyclonal) | Abcam | Cat. #: ab37152 | WB (1:1000) |
Antibody | Anti-Calnexin (goat polyclonal) | Abcam | Cat. #: ab192439 | IF (1:500) |
Antibody | Anti-ATF-6 (rabbit monoclonal) | Cell Signaling Technology | Cat. #: 65,880 | WB (1:1000) |
Antibody | Anti-Phospho-eIF2α (rabbit monoclonal) | Cell Signaling Technology | Cat. #: 3398 | WB (1:1000) |
Antibody | Anti-eIF2α (rabbit monoclonal) | Cell Signaling Technology | Cat. #: 5324 | WB (1:1000) |
Antibody | Anti-GAPDH (rabbit monoclonal) | Cell Signaling Technology | Cat. #: 2118 | WB (1:1000) |
Antibody | Anti-β-actin (rabbit polyclonal) | Thermo Fisher Scientific | Cat. #: PA1-183 | WB (1:1000) |
Antibody | Anti-GRP78 (mouse monoclonal) | Abcam | Cat. #: ab212054 | IF (1:500) |
Antibody | Anti-CD68 (rabbit polyclonal) | Abcam | Cat. #: ab125212 | IF (1:500) |
Antibody | Anti-rabbit IgG (H + L) Alexa Fluor 594 (goat polyclonal) | Thermo Fisher Scientific | Cat. #: A-11012 | IF (1:500) |
Antibody | Anti-mouse IgG (H + L) Alexa Fluor 488 (goat polyclonal) | Thermo Fisher Scientific | Cat. #: A-11001 | IF (1:500) |
Antibody | Anti-goat IgG H&L Alexa Fluor 647 (donkey polyclonal) | Abcam | Cat. #: ab150131 | IF (1:500) |
Antibody | Anti-rabbit HRP-conjugated IgG secondary antibody (goat polyclonal) | Sigma-Aldrich | Cat. #: A0545 | WB (1:10,000) |
Chemical compound, drug | Celastrol | Nanjing Spring and Autumn Biological Engineering Co., Ltd | Purity >98% (HPLC) | |
Chemical compound, drug | Lipopolysaccharides from Escherichia coli O111:B4 | Sigma-Aldrich | Cat #: L4391 | LPS |
Chemical compound, drug | Sodium palmitate | Sigma-Aldrich | Cat #: P9767 | |
Chemical compound, drug | Biotin-PEG3-amine | Hunan Huateng Pharmaceutical Company | Cat#: 11,025 | |
Chemical compound, drug | Alkyne-PEG4-amine | Hunan Huateng Pharmaceutical Company | Cat#: 10,749 | |
Cell line (Mus musculus) | RAW264.7 cells | ATCC | TIB-71 | Authenticated (STR profiling) and mycoplasma test (absent) (Genetic Testing Biotechnology Corporation, Suzhou, China) |
Commercial assay or kit | TRIzol Reagent | Thermo Fisher Scientific | Cat. #: 15596026 | |
Commercial assay or kit | RevertAid first-strand cDNA synthesis kit | Thermo Fisher Scientific | Cat. #: K1622 | |
Commercial assay or kit | SYBR Green mix | QIAGEN | Cat. #: 204,056 | |
Sequence-based reagent | Mm_Cfd_1_SG | QIAGEN | Cat. #: QT00250495 | Cfd |
Sequence-based reagent | Mm_Fabp4_1_SG | QIAGEN | Cat. #: QT00091532 | Fabp4 |
Sequence-based reagent | Mm_Cebpa_1_SG | QIAGEN | Cat. #: QT00311731 | Cebpa |
Sequence-based reagent | Mm_Cpt1a_1_SG | QIAGEN | Cat. #: QT00106820 | Cpt1 |
Sequence-based reagent | Mm_Lep_1_SG | QIAGEN | Cat. #: QT00164360 | Lepa |
Sequence-based reagent | Mm_Pparg_1_SG | QIAGEN | Cat. #: QT00100296 | Pparg |
Sequence-based reagent | Mm_Retn_1_SG | QIAGEN | Cat. #: QT00093450 | Retn |
Sequence-based reagent | Mm_Ucp2_1_SG | QIAGEN | Cat. #: QT00138943 | Ucp2 |
Sequence-based reagent | Mm_Crat_1_SG | QIAGEN | Cat. #: QT00111405 | Cat |
Sequence-based reagent | Mm_Acox1_1_SG | QIAGEN | Cat. #:QT00174342 | Aco |
Sequence-based reagent | Mm_Gapdh_3_SG | QIAGEN | Cat. #: QT01658692 | Gapdh |
Strain, strain background (Escherichia coli) | BL21(DE3) | Thermo Fisher Scientific | Cat. #: EC0114 | Competent cells |
Recombinant DNA reagent | pET-28a | Sigma-Aldrich | Cat. #: 69,864 | |
Recombinant DNA reagent | pET28a-GRP78 plasmid | This manuscript | See Materials and methods | |
Software, algorithm | Prism | GraphPad | https://www.graphpad.com/scientific-software/prism/ | |
Software, algorithm | NIH Image J | NIH | http://imagej.net/ImageJ2 |